Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir F. Udwadia; Pawan Singh; Hanmant Barkate; Saiprasad Patil; Shabbir Rangwala; Amol Pendse; Jatin Kadam; Wen Wu; Cynthia F. Caracta; Monika Tandon

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2020) - Comments
pubmed: 33212256 doi: 10.1016/j.ijid.2020.11.142 issn: 1201-9712 issn: 1878-3511

Zarir F. Udwadia, Pawan Singh, Hanmant Barkate, Saiprasad Patil, Shabbir Rangwala, Amol Pendse, Jatin Kadam, Wen Wu, Cynthia F. Caracta, Monika Tandon

Go to article

Elsevier BV